Finally, although OX108 has a relatively low affinity (KD = 84 nM), it is a well-documented CD200R-blocking antibody [24], and we were able to confirm successful tumour penetration and binding via a reduction of CD200R MFI on TIICs. Here, CD200R1 is linked to neoplasm.